Ilika plc Q&A with Dr Tom McColm at Baden Hill (LON:IKA)

Ilika Plc

Ilika plc (LON:IKA) is the topic of conversation when Baden Hill’s Partner and Equity Specialist Dr Tom McColm caught up with DirectorsTalk for an exclusive interview.

Q1: We’ve just seen that Ilika has published final results which were looking pretty good, where do you see the company’s first OEM licencing deal coming from?

A1: Yes, it’s a good question, it’s the thing that everyone’s looking for. I actually think it’ll be from one of the more specialised small scale Stereax applications and even though it was their latest and most recent product launch, the M50, this very very small millimetre scale device.

I think it will come for that product in the medical device application area because it’s such a high value add and there isn’t really any other batteries that can perform those sort of functions.

So, if I was a betting man, I’d say it’ll be an M50 application and what it definitely won’t be will be the big goliath cells in EV, I think that’s still a long way off.

Q2: So, what should investors be looking out for news flow wise over the next 12 months?

A2: Obviously, the one that I mentioned earlier, is we’re looking for this first big OEM licencing deal, it does seem like they’re getting closer and closer in a number of areas so that one will be a bit of a game changer.

Also, an important area is the relationship that they have with Semefab on the manufacturing side, information on that will be interesting, how that’s going, how that scale-up’s going because without that, the whole business model won’t work.

So, big first OEM licencing deal and good progress on the manufacturing partnership with Semefab.

Q3: Finally, what’s your view on the overall global battery market going forward?

A3: I think it’s just going to absolutely going to get massive. There’s two huge global megatrends at the moment, you’ve got the decarbonisation of energy and you’ve got the electrification of transport, both of those require vast amounts of storage.

Alongside that, you’ve still got the usual markets, consumer electronics markets, mobile phones etc. so I think there’s going to be a huge growth in the volume of batteries produced over the next 10/20 years.

Ilika plc is a pioneer in solid state battery technology. Ilika’s Stereax® state batteries include miniaturised products for powering wireless sensors in applications ranging from hostile industrial environments to medical implants.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Advancing solid-state batteries towards commercial reality

UK solid-state battery developer Ilika is progressing from pilot production to commercial validation in next-generation battery technology.

Ilika steps up commercial engagement at Stuttgart battery industry gathering

Ilika will present its solid-state battery capabilities at The Battery Show Europe 2026 as it strengthens engagement with Europe’s battery manufacturing ecosystem.

Ilika to present at Yellowstone Advisory Private Investor evening

Ilika announces that CEO Graeme Purdy and CFO Jason Stewart will present at the Yellowstone Advisory Private Investor evening on 25 February 2026 at Hudson Sandler, London.

10 Top ESG stocks on AIM 2026

These ten AIM-quoted ESG stocks offer investors exposure to companies where commercial progress and responsible business practices go hand in hand.

Ilika starts commercial supply to Cirtec

Ilika begins commercial delivery of Stereax electrodes under first supply order from Cirtec.

Dr Tom McColm on Ilika: Stereax revenues and Goliath milestones (LON:IKA)

Clean-tech equities specialist Dr Tom McColm reviews Ilika’s interim results, highlighting stable cash levels, the first recurring commercial revenues from Stereax, and continued technical and manufacturing progress on the Goliath battery platform.

Search

Search